skip to main content

Diabetic kidney disease — MCCQE Part 1 MCQ

Instant feedback + full explanation. One question, done properly.

HardChronic CareDiabetic kidney diseaseMCCQE Part 1

A 63-year-old man with type 2 diabetes and albuminuric chronic kidney disease has HbA1c 60 mmol/mol, eGFR 48 mL/min/1.73 m2, and urine albumin-creatinine ratio 42 mg/mmol. He takes metformin and an ACE inhibitor, and has no history of ketoacidosis. What is the most appropriate screening/prevention?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CAdd an SGLT2 inhibitor for kidney and cardiovascular protection

Diabetes Canada guidance supports SGLT2 inhibitors in type 2 diabetes with chronic kidney disease for kidney and cardiovascular benefit when eGFR permits. Persistent albuminuria is not a reason to stop a tolerated ACE inhibitor. Glyburide can cause hypoglycaemia and is not kidney-protective. Waiting until advanced CKD misses the prevention window.

Reference: Diabetes Canada 2024 pharmacologic update